A practical reference on synthetic peptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Melanocortin receptor agonist |
| Molecular formula | C50H69N15O9 | Neutral form, mass near 1024.2 g/mol |
| Primary targets | MC1R, MC3R, MC4R, MC5R | Binding is non-selective across subtypes |
| Related compounds | Alpha-MSH, melanotan I, afamelanotide | Structurally or functionally related peptides |
| Common abbreviations | MT-II, MT-2 | Naming in the literature is not uniform |
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
=== U.S. response on humanitarian aid === In May 2026, U.S. Secretary of State Marco Rubio said the United States had offered $100 million in humanitarian aid to Cuba, including food and medical supplies. He criticized the Cuban government, saying it was preventing humanitarian aid from reaching the population. The statement was made in the context of long-standing U.S. sanctions and trade restrictions on Cuba, which have restricted economic and humanitarian flows to the country. Rubio also described the situation in Cuba as "unacceptable" and called for major changes in the country's governance.
=== Pregnancy === Supplementation with a combination of vitamins E and C during pregnancy is not recommended by the World Health Organization. A Cochrane review concluded there was no support for the combination reducing risk of stillbirth, neonatal death, preterm birth, preeclampsia, or any other maternal or infant outcomes, either in healthy women or those considered at risk for pregnancy complications.
For services to the Post Office and to the community in Scunthorpe, Lincolnshire. Marion Constance Harrison. For services to the Schizophrenia Fellowship on Jersey. Maureen Hart, Personal Secretary, Vickers Defence Systems Ltd. For services to the Defence Industry. Patricia Mary Hart. For services to the community on Alderney. William Mark Hartley. For services to the community in Coventry. Dorothy Elizabeth Hawes, Vocal Department Consultant, Trinity College of Music, London. For services to Music Education. Judith Anne Hawkshaw. For services to Housing and the community in Suffolk. Shirley Caroline Amelia Hawley, lately Nursing Assistant, Pease Hill Residential Unit, Nottingham Healthcare Trust. For services to Health Care. Dinnie Margaret Hawthorne. For services to the community, particularly Elderly People in Bourne End, Buckinghamshire. Gordon Charles Hay, Gas Engineer. For humanitarian services to the former Yugoslavia. Arthur Rowland Hayter. For charitable services in Waterlooville, Hampshire. Desmond Heard, Gas Engineer. For humanitarian services to the former Yugoslavia. Albert Maurice Heath. For services to the Nevill Hall Hospital League of Friends, Abergavenny, Gwent. Alison Helen Constance Heath, Curator, the British Library. For services to Librananship and to Deaf People. Barbara Ceha Heath. For services to the community in Ringmer, East Sussex. Leslie Heath, Publican. For services to the community in East London. Patricia Ann Hedges, Education Advisor, Parcelforce. For services to the Freight Industry.
Sources: en.wikipedia.org
Abietanes may fall into one of two classes, either regular or phenolic. Regular abietanes are common across all conifers, whereas phenolic abietanes are usually found in more specific families and are mostly absent from pinaceae. There are a few exceptions to this, including detection of ferruginol and its derivative in Cedrus atlantica and Pinus sylvestris. Sugiol has been detected in Cupressaceae, Taxodiaceae, Podocarpaceae, and many other conifer families. It has not been significantly detected in Pinaceae. Similar phenolic abietanes have also been detected in cedars (genus Cedrus), pines (genus Pinus), monkey puzzle (genus Araucaria), and torreya (genus Torreya). Sugiol has also been detected in certain angiosperm genera such as Inula and Melia, but is much more prevalent in conifers. This allows for these organisms to be excluded from the list of species for which sugiol is a biomarker. The enzyme sugiol synthase has also been isolated from Salvia militiorrhiza, an angiosperm that contains high levels of phenolic diterpenes and is commonly utilized in traditional Chinese medicine.
The resultant breaking causes large-scale mixing of air and other trace gases throughout the midlatitude surf zone. The timescale of this rapid mixing is much smaller than the much slower timescales of upwelling in the tropics and downwelling in the extratropics. During northern hemispheric winters, sudden stratospheric warmings, caused by the absorption of Rossby waves in the stratosphere, can be observed in approximately half of the winters when easterly winds develop in the stratosphere. These events often precede unusual winter weather and may even be responsible for the cold European winters of the 1960s. Stratospheric warming of the polar vortex results in its weakening. When the vortex is strong, it keeps the cold, high-pressure air masses contained in the Arctic; when the vortex weakens, air masses move equatorward, and results in rapid changes of weather in the mid latitudes.
==== Germany ==== 4-HO-MET is ruled under the Neue-psychoaktive-Stoffe-Gesetz (NpSG) since July 18, 2019. Production and Import with intent to distribute is punishable. Possession is forbidden but not punishable, although ordering it in small quantities can still be seen as an intent to distribute it and be punished. 4-Propionoxy-N-methyl-N-ethyltryptamine (also referred to as 4-PrO-MET) is the ester prodrug of 4-HO-MET. Unlike many other tryptamine derivatives, it is currently not explicitly listed under the German Neue-psychoaktive-Stoffe-Gesetz (NpSG). This means that, while its use as a recreational substance is not legally permitted, the compound may be obtained and handled for legitimate research purposes, provided all other relevant legal requirements and safety regulations are observed.
Sources: en.wikipedia.org
Half-Life is a series of first-person shooter games created and published by Valve. Since the release of the original Half-Life for Windows in 1998, several Half-Life projects have been canceled, including some developed by other studios. In 1999, Valve canceled a Half-Life port for Mac developed by Logicware. Half-Life: Hostile Takeover, an expansion pack for Half-Life developed by 2015, was cancelled in 2000. In 2001, Sierra, the publisher of the original Half-Life, canceled a port for Dreamcast after Sega announced its discontinuation. After releasing Half-Life 2: Episode Two in 2007, Valve struggled to settle on a direction for a new Half-Life game. Episode Three was canceled after Valve abandoned episodic development and began developing a new game engine, Source 2. Another Half-Life 2 episode, by Junction Point Studios, was canceled after Junction Point was acquired by Disney Interactive Studios. Valve moved the project to Arkane Studios, who developed it as Ravenholm, set in the town infested with zombies from Half-Life 2 (2004). Valve canceled it as they felt it was creatively restrained. Valve developed Half-Life 3 between 2013 and 2014, experimenting with procedurally generated levels, but canceled it as the Source 2 engine was still unfinished. A virtual reality (VR) game set on a time-travelling ship, Borealis, was canceled as the VR technology and tools were not complete. As of 2025, datamines and leaks suggested that a Half-Life game codenamed HLX was in development using Source 2.
2H-Site-specific Natural Isotope Fractionation-Nuclear Magnetic Resonance (2H-SNIF-NMR) is a type of NMR specialized in measuring the 2H concentration of organic molecules at natural abundances. The NMR spectra distinguish hydrogen atoms in different chemical environments (e.g. the order of carbon that hydrogen binds to, adjacent functional groups, and even geminal positions of methylene groups), making it a powerful tool for position-specific isotope analysis. The chemical shift (in frequency units) of 2H is 6.5x lower than that of 1H. Thus, it is hard to resolve 2H peaks. To provide enough resolution to separate 2H peaks, high-strength magnetic field instruments (~11.4T) are applied. Use of NMR to study hydrogen isotopes of natural products, was pioneered by Gerard Martin and his co-workers in the 1980s. For several decades it has been developed and expanded. The D/H NMR measurement is sometimes coupled with IR-MS measurement to create a referential standard. The sensitivity of SNIF-NMR is relatively low, typically requiring ~1 mmol of samples for each measurement. The precision with respect to isotope ratio is also poor compared to mass spectrometry. Even state-of-art instruments can only measure DHR with around 50~200‰ error depending on the compound. Therefore, so far technique can only distinguish the large D/H variations in preserved materials. In 2007, Philippe Lesot and his colleagues advanced this technique with a 2-dimensional NMR using chiral liquid crystals (CLC) instead of isotropic solvents to dissolve organic molecules.
In the midst of this political climate, the two major events planned for 1992 ─ the 1992 Summer Olympics and the 1992 Seville Expo ─ were held, which provided "the opportunity to present Spain in the Columbus Quincentenary as a modern country, definitely away from the romantic stereotype (of charanga, tambourine, bandits and toreros)". This new image of Spain was accompanied by the strengthening of its international role, such as the holding in Madrid of the Middle East Peace Conference and the active participation of Felipe González in the approval of the Maastricht Treaty which transformed the European Community into the new European Union. Likewise, the Spanish government sent three Navy units to support US-led allied military operations during the First Gulf War of 1990–1991. However, the two great events of 1992 and the resounding success of the anti-terrorist policy that led to the arrest of the three top leaders of ETA in the French town of Bidart, could not hide the fact that a strong economic recession had begun, which resulted in a brutal increase in unemployment that would reach an unprecedented figure of 3.5 million unemployed, representing 24% of the working population. Also that same year, a general strike called by UGT and Comisiones Obreras occurred in protest against the government's "decretazo" cutting unemployment benefits. The deteriorating economic situation and social climate, together with internal divisions within the PSOE, led Felipe González to bring forward the general elections to June 1993.
The side effects of photodynamic therapy can be divided into onset side effects, which occur which early exposure to light. Early onset side effects of photodynamic Therapy (PDT) commonly include pain and Local Skin Reactions (LSRs), such as erythema, Edema, desquamation, and pustulae. These effects are frequently observed during or shortly after exposure to the light source used in PDT and may occur in combination. Less common side effects include urticaria, contact dermatitis, and erosive pustular dermatosis of the scalp (EPDS). Additionally, PDT can have an acute impact on the immune system, which, although immediate in onset, may have long-term implications for treatment-related changes in carcinogenesis. Late onset side effects, include pigmentary changes and scarring, affecting approximately 0.8% of patients. There is also a risk of developing bullous pemphigoid, and there is potential for PDT to induce or stimulate skin carcinogenesis.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide and a non-selective melanocortin receptor agonist. Structurally it is modelled on alpha-melanocyte-stimulating hormone, a peptide that occurs naturally in the body.
Activation of MC1R increases pigment synthesis independently of ultraviolet exposure, which is the mechanism usually cited for darkening without sun exposure. Ultraviolet light still influences skin response through separate biological pathways.
Because the peptide binds several melanocortin receptor subtypes, its effects are not confined to pigmentation. This complicates interpretation of both intended and unintended outcomes reported in studies.
No. It is a laboratory-made peptide, while the natural hormone is alpha-melanocyte-stimulating hormone, a longer peptide produced by the pituitary gland and by skin cells. Melanotan-2 mimics only a short active region of that hormone and contains non-natural residues such as D-phenylalanine.